Open Access<p>Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort</p>
Author(s) -
Paolo Bonfanti,
Andrea De Vito,
Elena Ricci,
Barbara Menzaghi,
Giancarlo Orofino,
Nicola Squillace,
Chiara Molteni,
Giuseppe Vittorio De Socio,
E Salomoni,
Benedetto Maurizio Celesia,
Chiara Dentone,
Valeria Colombo,
Giordano Madeddu
Publication year - 2020
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s260449
Subject(s) - medicine , dolutegravir , bone mineral , osteoporosis , confidence interval , femoral neck , osteopenia , adverse effect , cohort , urology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , family medicine
Few data exist about the effect of dolutegravir (DTG) on bone mineral density (BMD) in real life. The aim of this study was to determine rates of change in BMD over time in people living with HIV (PLWH) treated with DTG.